These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 8752932)

  • 1. Calpain is the target antigen of a Th1 clone that transfers protective immunity against Schistosoma mansoni.
    Jankovic D; Aslund L; Oswald IP; Caspar P; Champion C; Pearce E; Coligan JE; Strand M; Sher A; James SL
    J Immunol; 1996 Jul; 157(2):806-14. PubMed ID: 8752932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
    Mountford AP; Anderson S; Wilson RA
    J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity.
    Williams ME; Caspar P; Oswald I; Sharma HK; Pankewycz O; Sher A; James SL
    J Immunol; 1995 May; 154(9):4693-700. PubMed ID: 7722322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell clones for antigen selection and lymphokine production in murine Schistosomiasis mansoni.
    Reynolds SR; Kunkel SL; Thomas DW; Higashi GI
    J Immunol; 1990 Apr; 144(7):2757-62. PubMed ID: 1690777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. III. Correlation of resistance with induction of activated larvacidal macrophages.
    James SL
    J Immunol; 1986 May; 136(10):3872-7. PubMed ID: 3084646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of protective immunity against Schistosoma mansoni by a non living vaccine. I. Partial characterization of antigens recognized by antibodies from mice immunized with soluble schistosome extracts.
    James SL; Pearce EJ; Sher A
    J Immunol; 1985 May; 134(5):3432-8. PubMed ID: 3980998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms.
    Jankovic D; Wynn TA; Kullberg MC; Hieny S; Caspar P; James S; Cheever AW; Sher A
    J Immunol; 1999 Jan; 162(1):345-51. PubMed ID: 9886405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
    James SL; DeBlois LA
    J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
    Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A
    J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine.
    Street M; Coulson PS; Sadler C; Warnock LJ; McLaughlin D; Bluethmann H; Wilson RA
    J Immunol; 1999 Oct; 163(8):4489-94. PubMed ID: 10510391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the immunodominant T cell epitope of p38, a major egg antigen, and characterization of the epitope-specific Th responsiveness during murine schistosomiasis mansoni.
    Chen Y; Boros DL
    J Immunol; 1998 Jun; 160(11):5420-7. PubMed ID: 9605143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase.
    Reynolds SR; Dahl CE; Harn DA
    J Immunol; 1994 Jan; 152(1):193-200. PubMed ID: 7504709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
    Hoffmann KF; James SL; Cheever AW; Wynn TA
    J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
    Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
    J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of protective immunity against Schistosoma mansoni by vaccination with schistosome paramyosin (Sm97), a nonsurface parasite antigen.
    Pearce EJ; James SL; Hieny S; Lanar DE; Sher A
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5678-82. PubMed ID: 3135553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with SmIg, a novel tegument protein from Schistosoma mansoni, fails to induce protection in mice but reduces liver pathology.
    Pinho JM; Cardoso FC; Lopes DO; Pinheiro CS; Caliari MV; Oliveira FM; Leite LC; Oliveira SC
    Parasitology; 2010 Jun; 137(7):1079-88. PubMed ID: 19835649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of interleukin-1 and interleukin-6 in murine primary schistosomiasis.
    El Ridi R; Wagih A; Salem R; Mahana N; El Demellawy M; Tallima H
    Int Immunopharmacol; 2006 Jul; 6(7):1100-8. PubMed ID: 16714213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Schistosoma mansoni 22.6 kDa antigen induces partial protection against experimental infection in a recombinant protein form but not as DNA vaccine.
    Pacífico LG; Fonseca CT; Chiari L; Oliveira SC
    Immunobiology; 2006; 211(1-2):97-104. PubMed ID: 16446174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
    James SL; Lazdins JK; Hieny S; Natovitz P
    J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.